Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Effective January 7, 2018, Enochian Biosciences, Inc. (the "Company"), hired
Luisa Puche as its full-time Chief Financial Officer to support the Company's
growth as an exchange listed Company.
Ms. Puche, aged 55, has worked as a senior accounting and financial advisor and
as President of Puche Group, LLC, an audit, regulatory, and corporate advisory
consultancy, since 2015. Between 2010 and 2014, Ms. Puche served in various
senior executive roles at Brightstar Corp., a global wireless device services
provider, including as Vice President and Global Controller and as Interim Chief
Accounting Officer. Ms. Puche also previously worked at Ernst and Young, most
recently as Associate Director of the Security & Technology Solutions Consulting
Practice from 200 through 2004. Ms. Puche holds a BS in Accounting from Florida
In connection with her employment as Chief Financial Officer, Ms. Puche will
receive an annual salary of $200,000 and eligibility for a bonus, with a target
of 40% of her annual salary. Ms. Puche will also be entitled to receive a grant
of 60,000 stock options and 15,000 shares of restricted stock under the
Company's 2014 Equity Incentive Plan, which will vest annually over three years.
Other than the foregoing, there are no arrangements or understandings between
Ms. Puche and any person (including the Company) pursuant to which Ms. Puche was
appointed to serve as Chief Financial Officer, and there are no actual or
proposed transactions between Ms. Puche or any of her related persons and the
Company that would require disclosure under Item 404(a) of Regulation S-K in
connection with her appointment as Chief Financial Officer.
Additionally, following the appointment of Ms. Puche, on January 9, 2019 the
Company terminated the consulting agreement between its wholly-owned subsidiary
Enochian BioSciences Denmark ApS and Crossfield, Inc. for the services of Robert
Wolfe as part-time Chief Financial Officer of the Company.
© Edgar Online, source Glimpses